7148 DPHARMA | Malaysia


RM 3.56 on: 2021-01-18

+0.56% Past 1-day return
+6.59% Past 5-day return

Covid19 Upside Pharmaceuticals

Price/Valuation Analysis
Current Price Status
  • Stock is in Momentum

    Stock is currently overvalued by the market with the expectation of annual earning growth at 45.21% to match current price.

    Overvalued stock can be traded very volatile. If the earning growth momentum continue, overvalued stock can match into fair value, on the flip side, the downside risk can be huge if the stock is not meeting the market expectation.

  • Company is in Positive Earning
Fair Value
  • DPHARMA current price is 12.66% above OneDelta estimated fair value.
  • The fair value is estimated via OneDelta proprietary model that updated daily basis based on stock fundamental and specific industry relative marco outlook. It can be assessed as stock potential upside range or the stock true value price in case of downside.

Relative Price Performance
  • Outperformed
    DPHARMA past 5-day return perform better than Pharmaceuticals industry average return by 0.57%
  • Above 30-Day Average
    Current price RM3.56 is above than 30-day average RM3.49 by 2%

Return (%) DPHARMA Pharmaceuticals
1-Day+0.56% +1.79%
5-Day+6.59% +6.02%
30-Day-6.56% +0.63%
Bank Analyst Price Targets
No recent bank analyst price target available yet
Revenue & Earning Growth Analysis
  • Recent Weak Revenue Growth

    DPHARMA posted a weaker revenue growth in the recent quarter than normal average.

  • Unstable Profit Growth

    DPHARMA has been experiencing substantial ups and downs on profit growth.

Past Quarter Reports
Quarter Date Revenue (RM) (%) EPS (RM) (%)
2020-09-30 133,772k -7% 0.0203 -6%
2020-06-30 143,331k -10% 0.0215 +9%
2020-03-31 158,713k +15% 0.0198 +13%
2019-12-31 137,755k -4% 0.0176 -20%
2019-09-30 142,855k -2% 0.022 +6%
Volume Trend Analysis
  • Recent Volume is Increasing

    Surge in trading volume tends to bring more price volatility in near term.

  • DPHARMA recent daily traded volume is 31.82% higher than past month average.

Past 30-Day Past 5-Day
44k daily58k daily
Price History Chart
Past 30-day Average Price: RM3.49
Stock Fundamental Factors

Fundamental factor characteristics help us understand and expect how the stock price will behave in short and long term.

Stock Thematic Baskets

Usually the more the stock is included in popular themes, the more opportunity for price-driven momentum and better liquidity.

Stock Company Profile

Duopharma Biotech Bhd. is an investment holding company, which engages in the research, development, and commercialization of chemical and pharmaceutical products. Its products include tablets, capsules, syrup, antibiotic, creams, haemodialysis solution, sterile irrigation solution, sterile powder injectibles, small volume injectibles, dental cartridges, and eye drop preparations. The company was founded in 1979 and is headquartered in Klang, Malaysia.